Streptococcus Infection
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
A Strep Throat Controlled Human Infection Trial in Healthy Adults
Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia
Necrotizing Bacterial Dermohypodermitis-necrotizing Fasciitis Mono- or Multi-microbial Streptococcus Beta-haemolytic
Streptoccus Pseudopneumoniae atAssiut UniversityHospitals
Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy